Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.
Perpetual Ltd bought a new stake in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,907 shares of
Amgen Inc. (NASDAQ: AMGN - Get Free Report) has been given an average rating of "Moderate Buy" by the twenty-two ratings firms that are presently covering the company, Marketbeat reports. One research
CHICAGO TRUST Co NA decreased its stake in Amgen Inc. (NASDAQ: AMGN) by 60.5% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fi
Yield, sector focus, and risk profiles set these two dividend ETFs apart-see how their distinct strategies may fit different investor goals.
Bartlett and CO. Wealth Management LLC cut its holdings in Amgen Inc. (NASDAQ: AMGN) by 2.1% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchan
Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.
CNBC's “Closing Bell Overtime” team discusses why the biotech recovery may continue into 2026 with Salveen Richter, lead U.S. biotech analyst at Goldman Sachs Research.
Guru Stock PicksVanguard Health Care Fund has made the following transactions:Reduce in ARGX by 14.38%Sold out in PACSAdd in CLDX by 3.64%New position in PTGXCI
Officials pledge ‘massive savings' as companies agree to offer drugs at prices paid in other wealthy countries
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug
Underscores Long-Standing Commitment to Investing in Innovation and U.S. Manufacturing THOUSAND OAKS, Calif. , Dec. 19, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced it is taking action aga
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
Amgen (NASDAQ: AMGN - Get Free Report) and Dynavax Technologies (NASDAQ: DVAX - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based o
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE